Hennepin Life Sciences
Mr. Killeen has been the Controller of Hennepin Life Sciences since January 2013. He has over twelve years of experience as an accounting professional, and over five years of financial management in the medical industry, most recently serving as financial reporting manager at Cardiovascular Systems, Inc. (Roseville, MN). Previously, from 2003 to 2007, Mike served as a supervisor and auditor in the public accounting industry at Grant Thornton, LLP (Minneapolis, MN) and completed a two-year secondment overseas in Hong Kong, China serving American clients with international operations. From 2007 to 2009, he worked as a financial reporting analyst at Compellent Technologies in another technology-based growth environment following their initial public offering. Mr. Killeen is a licensed C.P.A (inactive) in the State of Minnesota and has a degree in accounting and management information systems from Luther College.
This person is not in any teams
This person is not in any offices
Hennepin Life Sciences
Hennepin Life Sciences is a growth-stage human and animal health company that is uniquely focused on the development of patent-protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections.